Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Change in Accured Expenses (2016 - 2025)

CV Sciences' Change in Accured Expenses history spans 14 years, with the latest figure at -$563000.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 72.17% year-over-year to -$563000.0; the TTM value through Sep 2025 reached -$1.1 million, down 35.08%, while the annual FY2024 figure was -$603000.0, 88.44% down from the prior year.
  • Change in Accured Expenses for Q3 2025 was -$563000.0 at CV Sciences, down from $34000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.4 million in Q3 2021 and bottomed at -$598000.0 in Q2 2021.
  • The 5-year median for Change in Accured Expenses is -$187000.0 (2024), against an average of -$84473.7.
  • The largest annual shift saw Change in Accured Expenses skyrocketed 2626.67% in 2021 before it tumbled 1155.0% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.2 million in 2021, then tumbled by 101.63% to -$20000.0 in 2022, then crashed by 1155.0% to -$251000.0 in 2023, then skyrocketed by 86.85% to -$33000.0 in 2024, then crashed by 1606.06% to -$563000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Change in Accured Expenses are -$563000.0 (Q3 2025), $34000.0 (Q2 2025), and -$547000.0 (Q1 2025).